focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 3.50 (5.34%)
Spread: 2.00 (2.941%)
Open: 65.50
High: 69.00
Low: 65.50
Prev. Close: 65.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NetScientific CEO stands down to assist with cost reduction efforts

Thu, 25th Apr 2019 08:48

(Sharecast News) - NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.The AIM-listed outfit's chief financial officer and company secretary Ian Postlethwaite will now combine his existing roles with that of chief executive.Chairman Richard Sykes said: "The board would like to put on record its gratitude to François for his leadership of NetScientific since 2015 in a challenging IP commercialisation environment and wishes him every success in his future interests."We will seek to make the most of our reduced central costs with the aim of maximising the potential in our remaining portfolio companies."Elsewhere, NetScientific revealed that the lease on its London headquarters was terminated on 29 March as it continues to review all other activities in order to manage its cash resources effectively.As of 0845 BST, NetScientific shares had tumbled 18% to 8.20p.
More News
26 Oct 2021 17:39

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

Read more
22 Oct 2021 18:07

IN BRIEF: NetScientific's ProAxsis gets approval of key US patent

IN BRIEF: NetScientific's ProAxsis gets approval of key US patent

Read more
22 Oct 2021 06:51

IN BRIEF: NetScientific's PDS temporarily suspends trial recruitment

IN BRIEF: NetScientific's PDS temporarily suspends trial recruitment

Read more
5 Oct 2021 22:06

TRADING UPDATES: Inland gets Basildon permission; ICG assets grow

TRADING UPDATES: Inland gets Basildon permission; ICG assets grow

Read more
29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

Read more
22 Sep 2021 17:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Sep 2021 18:04

IN BRIEF: NetScientific invests GBP1 million into Martlet Capital

IN BRIEF: NetScientific invests GBP1 million into Martlet Capital

Read more
16 Jun 2021 13:58

IN BRIEF: NetScientific's PDS Biotechnology raises USD45 million

IN BRIEF: NetScientific's PDS Biotechnology raises USD45 million

Read more
15 Jun 2021 21:40

IN BRIEF: NetScientific's PDS Biotechnology starts offer of stock

IN BRIEF: NetScientific's PDS Biotechnology starts offer of stock

Read more
10 Jun 2021 19:46

TRADING UPDATES: Ergomed and Dekel Agri-Vision earnings growing

TRADING UPDATES: Ergomed and Dekel Agri-Vision earnings growing

Read more
8 Jun 2021 15:45

NetScientific shares jump again after portfolio company's strong data

NetScientific shares jump again after portfolio company's strong data

Read more
7 Jun 2021 12:09

LONDON MARKET MIDDAY: FTSE 100 outperforms as UK housebuilders rally

LONDON MARKET MIDDAY: FTSE 100 outperforms as UK housebuilders rally

Read more
7 Jun 2021 10:48

NetScientific shares surge on AstraZeneca Covid-19 test contract

NetScientific shares surge on AstraZeneca Covid-19 test contract

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more
7 Jun 2021 09:38

NetScientific subsidiary strikes exclusive licensing deal with AstraZeneca

(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.